(Q34328987)

1 August 2017

title

Technical report: Ethical and policy issues in genetic testing and screening of children (English)

1 reference

American Academy of Pediatrics

1 August 2017

0 references

0 references

0 references

5

object named as

American Academy of Pediatrics

1 reference

1 August 2017

1

Lainie Friedman Ross

1 reference

1 August 2017

Howard M Saal

2

1 reference

1 August 2017

Karen L David

3

1 reference

1 August 2017

Rebecca R Anderson

4

1 reference

1 August 2017

American College of Medical Genetics and Genomics

6

1 reference

1 August 2017

language of work or name

English

0 references

publication date

21 February 2013

1 reference

1 August 2017

1 reference

1 August 2017

volume

15

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

234-245

1 reference

Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

THE CHROMOSOME NUMBER OF MAN

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

A 30-month-old boy with developmental regression and hepatosplenomegaly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Clinical pharmacogenetics in pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Pharmacogenetics in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Pharmacogenomics of pediatric acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Pharmacogenetic approach for a better drug treatment in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

A current update on ADHD pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Pharmacogenetic insights into codeine analgesia: implications to pediatric codeine use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Pharmacogenetics of codeine metabolism in an urban population of children and its implications for analgesic reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Genetic ancestry modifies pharmacogenetic gene-gene interaction for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Pharmacogenomics and the future of drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Newborn blood spot screening: new opportunities, old problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Patient advocacy in newborn screening: continuities and discontinuities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

The genetic testing of children. Working Party of the Clinical Genetics Society (UK)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Impact of false-positive newborn metabolic screening results on early health care utilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Psychosocial Consequences of False-Positive Newborn Screens for Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Parents' experiences of expanded newborn screening evaluations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Patients-in-waiting: Living between sickness and health in the genomics era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Newborn screening technology: proceed with caution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Committee report: Method for evaluating conditions nominated for population-based screening of newborns and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

American Academy of Pediatrics Newborn Screening Task Force recommendations: how far have we come?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Parental attitudes regarding newborn screening of PKU and DMD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Newborn screening: an appeal for improved parent education

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

New technologies extend the scope of newborn blood-spot screening, but old problems remain unresolved

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

From public health emergency to public health service: the implications of evolving criteria for newborn screening panels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

A blueprint for maternal and child health primary care physician education in medical genetics and genomic medicine: recommendations of the United States secretary for health and human services advisory committee on heritable disorders in newborns a

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Effects of genetic risk information on children's psychosocial wellbeing: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Complications associated with sickle cell trait: a brief narrative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Screening U.S. college athletes for their sickle cell disease carrier status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

The fragile-X premutation: a maturing perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Heterozygote carrier testing in high schools abroad: what are the lessons for the U.S.?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

A systematic review of literature about the genetic testing of adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Genetic testing for cancer predisposition and implications for nursing practice: narrative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Predictive, pre-natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Problems assessing uptake of Huntington disease predictive testing and a proposed solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Psychological impact of genetic testing for Huntington's disease: an update of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Using the Best Interests Standard to decide whether to test children for untreatable, late-onset genetic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Parents' attitudes toward pediatric genetic testing for common disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Understandings of basic genetics in the United States: results from a national survey of black and white men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Men's decision-making about predictive BRCA1/2 testing: the role of family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Family Systems genetic Illness Model--breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

The role of the family in genetic testing: theoretical perspectives, current knowledge, and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Genetic testing and the family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Confidentiality, consent, and caring for the adolescent patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Adolescents and informed consent: ethical and legal issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Minors as living solid-organ donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

The ethics of preadoption genetic testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Predictive testing for pre-malignancy as a prelude to adoption? An English case.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Childhood genetic testing for familial cancer: should adoption make a difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Family history and adoption in the UK: conflicts of interest in medical disclosure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Donor conception and children's rights: a parent's decision

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

UK gamete donors' reflections on the removal of anonymity: implications for recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Donor gametes: anonymous or identified?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Families and adoption: the pediatrician's role in supporting communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Genetic professionals' reports of nondisclosure of genetic risk information within families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Disclosure of a diagnosis to children and adolescents when parents object. A clinical ethics analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Disclosure of HIV diagnosis to children: when, where, why, and how.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Communicating with children and families: from everyday interactions to skill in conveying distressing information

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Disclosure of misattributed paternity: issues involved in the discovery of unsought information.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Misattributed paternity in a living related donor: to disclose or not to disclose?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Good ethics requires good science: why transplant programs should not disclose misattributed parentage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Paternity testing with an absent mother. The probability of exclusion of red cell surface antigen, Gm, Hp, and HLA systems in North American whites and blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

ASHG Statement* on Direct-to-Consumer Genetic Testing in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Social networkers' attitudes toward direct-to-consumer personal genome testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Challenges in the use of direct-to-consumer personal genome testing in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Associations between anticipated reactions to genetic test results and interest in genetic testing: will self-selection reduce the potential for harm?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Primary care physicians as providers of frontline genetic services

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Genetics and the general pediatrician: where do we belong in this exploding field of medicine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

The emerging role of primary care in genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Communicating genetic information: a difficult challenge for future pediatricians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Expanded newborn screening in Texas: a survey and educational module addressing the knowledge of pediatric residents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Newborn screening fact sheets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Differential use of available genetic tests among primary care physicians in the United States: results of a national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

Ethical issues with genetic testing in pediatrics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

7 January 2021

Incidental discovery of nonpaternity during prenatal testing of genetic disease

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

7 January 2021

Pharmacogenetics of anti-inflammatory treatment in children with asthma: rationale and design of the PACMAN cohort

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

7 January 2021

State newborn screening in the tandem mass spectrometry era: more tests, more false-positive results

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

7 January 2021

Expanded newborn screening for biochemical disorders: the effect of a false-positive result

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

7 January 2021

Newborn screening--setting evidence-based policy for protection

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

7 January 2021

Recommendations for effective newborn screening communication: results of focus groups with parents, providers, and experts

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

7 January 2021

Incorporating newborn screening into prenatal care

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

7 January 2021

Newborn screening expands: recommendations for pediatricians and medical homes--implications for the system

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

7 January 2021

Should parental refusals of newborn screening be respected?

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

7 January 2021

A survey to evaluate parental consent as public policy for neonatal screening

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

7 January 2021

Expanded newborn screening: reducing harm, assessing benefit

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

7 January 2021

Genetic testing for late-onset diseases: effect of disease controllability, test predictivity, and gender on the decision to take the test

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

7 January 2021

The micropolitics of responsibility vis-à-vis autonomy: parental accounts of childhood genetic testing and (non)disclosure

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

7 January 2021

Children as hematopoietic stem cell donors

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

7 January 2021

Thinking ethically about genetic inheritance: liberal rights, communitarianism and the right to privacy for parents of donor insemination children

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

7 January 2021

Legislated right for donor-insemination children to know their genetic origin: a study of parental thinking

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

7 January 2021

Does "telling" less protect more? Relationships among age, information disclosure, and what children with cancer see and feel

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

7 January 2021

Disclosure of Illness Status to Children and Adolescents With HIV Infection

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

7 January 2021

Mother-child exclusion due to paternal uniparental disomy 6

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

7 January 2021

Primary care physicians' attitudes regarding follow-up care for children with positive newborn screening results

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

7 January 2021

Primary care clinicians' knowledge and confidence about newborn screening for sickle cell disease: randomized assessment of educational strategies.

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2012.176

7 January 2021

Identifiers

DOI

10.1038/GIM.2012.176

1 reference

1 August 2017

1 reference